Long-term versus short-term androgen deprivation combined with high-dose radiotherapy for intermediate and high-risk prostate cancer: A randomized controlled trial (DART01/05).

被引:0
|
作者
Zapatero, Almudena
Guerrero, Araceli
Maldonado, Xavier
Alvarez, Ana
San Segundo, Carmen Gonzalez
Cabeza Rodriguez, Maria Angeles
Macias, Victor
Casas, Francesc
Pedro-Olive, Agusti
Boladeras, Ana Maria
de Vidales, Carmen Martin
Vazquez de La Torre, Maria Luisa
Villa, Salvador
Calvo, Felipe A.
机构
[1] Hosp Univ Princesa, Dept Radiat Oncol, Madrid, Spain
[2] Hosp Son Dureta, Palma de Mallorca, Spain
[3] Vail dHebron Univ Hosp, Barcelona, Spain
[4] Hosp Univ Gregorio Maranon, Madrid, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Univ Salamanca, Hosp Gen Catalunya, Barcelona, Spain
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Clin Plato, Barcelona, Spain
[9] ICO Hosp, Inst Catala Oncol, IDIBELL, Barcelona, Spain
[10] Hosp Meixoeiro, Vigo, Spain
[11] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain
[12] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
关键词
D O I
10.1200/jco.2014.32.15_suppl.5038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5038
引用
收藏
页数:1
相关论文
共 50 条
  • [1] High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
    Zapatero, Almudena
    Guerrero, Araceli
    Maldonado, Xavier
    Alvarez, Ana
    Gonzalez San Segundo, Carmen
    Cabeza Rodriguez, Maria Angeles
    Macias, Victor
    Pedro Olive, Agusti
    Casas, Francesc
    Boladeras, Ana
    Martin de Vidales, Carmen
    Vazquez de la Torre, Maria Luisa
    Villa, Salvador
    Perez de la Haza, Aitor
    Calvo, Felipe A.
    LANCET ONCOLOGY, 2015, 16 (03): : 320 - 327
  • [2] Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza, A.
    Macias, V.
    Casas, F.
    Pedro-Olive, A.
    Villa, S.
    Boladeras, A.
    Vazquez de La Torre, M. L.
    Martin de Vidales, C.
    Calvo, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Re: High-Dose Radiotherapy with Short-Term or Long-Term Androgen Deprivation in Localised Prostate Cancer (DART01/05 GICOR): A Randomised, Controlled, Phase 3 Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 194 (04): : 989 - 990
  • [4] High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial (vol 16, pg 320, 2015)
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    LANCET ONCOLOGY, 2015, 16 (06): : E262 - E262
  • [5] Long-term vs. Short-term Androgen Deprivation Combined with High-dose Radiotherapy for Intermediate and High-risk Prostate Cancer: Preliminary Results of a GICOR Phase III Randomized Trial
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Cabeza, A.
    Gonzalez San Segundo, C.
    Macias, V.
    Casas, F.
    Pedro-Olive, A.
    Boladeras, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S40 - S40
  • [6] LONG-TERM VERSUS SHORT-TERM ANDROGEN DEPRIVATION COMBINED WITH HIGH-DOSE CONFORMAL RADIOTHERAPY (HDCRT) FOR PATIENTS WITH LOCALIZED PROSTATE CANCER: FIRST REPORT ON COMPLIANCE, FEASIBILITY AND SAFETY RESULTS FROM GICOR DART 01 TRIAL
    Zapatero, A.
    Alvarez, A.
    Maldonado, X.
    Guerrero, A.
    Macias, V.
    Cabeza, A.
    San-Segundo, C. Gonzalez
    Casas, F.
    Olive, A. Pedro
    Calvo, F. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 197 - 197
  • [7] <bold>Long-term versus short-term androgen deprivation combined </bold>with high-dose radiotherapy for localized prostate cancer: A Spanish multicenter phase III trial.
    Zapatero, A.
    Guerrero, A.
    Maldonado, X.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza, A.
    Macias, V.
    Casas, F.
    Pedro-Olive, A.
    Calvo, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Even high-dose radiotherapy requires long-term androgen ablation for high-risk prostate cancer
    Nam, T. K.
    Kwon, D. D.
    Jeong, J. W.
    Kim, Y. H.
    Yoon, M. S.
    Song, J. Y.
    Ahn, S. J.
    Chung, W. K.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S346 - S346
  • [9] Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial
    Berghen, Charlien
    Joniau, Steven
    Laenen, Annouschka
    Devos, Gaetan
    Rans, Kato
    Goffin, Karolien
    Haustermans, Karin
    De Meerleer, Gert
    FUTURE ONCOLOGY, 2020, 16 (27) : 2035 - 2044
  • [10] Long-term versus short-term androgen deprivation combined with EBRT for unfavourable prostate cancer
    Crook, Juanita
    LANCET ONCOLOGY, 2022, 23 (05): : 558 - 560